Publication | Closed Access

A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

NanomedicineAntitumor ActivityPolymer-drug ConjugateMedicineDrug Delivery SystemsNano-drug DeliveryPharmacotherapyTumor TargetingDrug Delivery SystemPharmacologyRadiation OncologyPegylated Dendrimer